2020 ASCO Virtual Direct™ Highlights

 

GU
13:29

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Diagnostic/Prognostic Testing in PC: Is 68Ga- PSMA-11 PET More Accurate for Detection of N1 vs. Histopathology at Time of RP? Is 18F-DCFPyL PET/CT More Sensitive for Detection of Recurrent Disease vs. Standard Imaging Agents?

FEATURING William Kelly
  • 96 views
  • July 15, 2020
05:17

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on mCRPC: Is 177Lu-PSMA-617 Superior PSA Response Rate vs. Cabazitaxel Practice Changing?

FEATURING William Kelly
  • 84 views
  • July 15, 2020
10:14

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Prostate Cancer: Is Testosterone Suppression With an Oral GnRH Antagonist Relugolix Comparable to Leuprolide?

FEATURING William Kelly
  • 452 views
  • July 15, 2020
  • 4
17:12

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on mUC: Does Switch Maintenance Avelumab + BSC Prolong OS in Patients Who Achieved a Response or Stable Disease to a First-line Platinum-based Chemotherapy?

FEATURING Joseph Kim
  • 219 views
  • July 15, 2020
08:55

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced RCC: Pembrolizumab + Axitinib vs. Sunitinib - Is IO Combination Continuing to Demonstrate Clinical Efficacy?

FEATURING Joseph Kim
  • 88 views
  • July 15, 2020
07:08

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced RCC: Efficacy and Safety Analysis of Nivolumab Monotherapy vs. Nivolumab + Ipilimumab in Treatment-naive Patients

FEATURING Joseph Kim
  • 79 views
  • July 15, 2020